Abbott Pacemaker Receives FDA Approval

{
  "signal_id": "3c3bb12f-a7d6-3e7c-7073-916e59eab2e8",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-09-16T23:33:19+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "url": "https://www.dicardiology.com/content/abbott-pacemaker-receives-fda-approval",
    "title": "Abbott Pacemaker Receives FDA Approval - dicardiology.com",
    "excerpt": "Sept. 15, 2026 - The Food & Drug Administration has approved Abbott’s AVEIR VR Mini Ventricular leadless pacemaker (LP), the latest-generation ventricular device in Abbott’s AVEIR leadless pacing platform. The shorter length of this device expands implant options within the right ventricle and more implant options for treating patients with slow heart rhythms. Together with the AVEIR AR2 Atrial LP, the AVEIR VR Mini Ventricular LP represents the next important evolution of the AVEIR DR LP system, a dual-chamber leadless pacemaker. Powered by Abbott’s i2i (implant-to-implant) in-body communication technology, the AVEIR DR system enables beat-to-beat communication between two leadless pacemakers to maintain synchronous activation of the heart. The AVEIR VR Mini Ventricular LP is shortened from 38.0 to 32.5 mm, a 14% reduction compared to the existing AVEIR VR Ventricular LP, while delivering industry-leading ventricular longevity in a smaller form factor. The device provides an additional option for patients who would benefit from use of a lower-profile device. Unlike traditional pacemakers, leadless pacemakers are implanted directly into the heart through a minimally invasive catheter-based procedure and eliminate the need for cardiac leads. The procedure leaves no chest scar, and the device is not visible to the eye. “Abbott is advancing leadless pacing and expanding options...",
    "product": "AVEIR VR Mini Ventricular leadless pacemaker",
    "summary": "Abbott's AVEIR VR Mini Ventricular leadless pacemaker (LP) has received approval from the U.S. Food & Drug Administration.",
    "planning": false,
    "image_url": "http://www.dicardiology.com/sites/default/files/Abbott%20AVEIRVRMiniLP.png",
    "confidence": 0.95,
    "product_data": {
      "name": "AVEIR VR Mini Ventricular leadless pacemaker",
      "full_text": "Abbott’s AVEIR VR Mini Ventricular leadless pacemaker (LP), the latest-generation ventricular device in Abbott’s AVEIR leadless pacing platform",
      "fuzzy_match": false,
      "release_type": "model"
    },
    "product_tags": [
      "general_technology",
      "medical"
    ],
    "published_at": "2026-09-16T23:33:19Z",
    "effective_date": "2026-09-15",
    "article_sentence": "The Food & Drug Administration has approved Abbott’s AVEIR VR Mini Ventricular leadless pacemaker (LP), the latest-generation ventricular device in Abbott’s AVEIR leadless pacing platform."
  }
}

curl https://signals.autobound.ai/v1/signals/3c3bb12f-a7d6-3e7c-7073-916e59eab2e8 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbott.com","limit":20}'